$DVAX Recent Headlines Ascena Retail shares rally after

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$DVAX Recent Headlines

Ascena Retail shares rally after hours 4:50 p.m. Sept. 24, 2013 - Wallace Witkowski
FDA: Dynavax hep B vaccine needs more evaluation 6:49 a.m. Feb. 25, 2013 - MarketWatch.com
Dynavax Tech down 14% in premarket 7:51 a.m. Dec. 3, 2012 - Steve Gelsi
Dynavax Tech off 17% in premarket trades 7:38 a.m. Nov. 29, 2012 - Steve Gelsi
Dynavax Tech falls 49% in premarket trades 8:42 a.m. Nov. 16, 2012 - Steve Gelsi
Wednesday’s biggest gaining and declining stocks 1:42 p.m. May 9, 2012 - MarketWatch
Dynavax tumbles 24% on stock offer pricing 11:05 a.m. May 9, 2012 - Val Brickates Kennedy
Dynavax jumps 25% on FDA update 8:45 a.m. July 28, 2011 - Val Brickates Kennedy
Dynavax plunges 16% on mixed study results 10:26 a.m. July 20, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 4:57 p.m. Sept. 21, 2010 - MarketWatch
Drug stocks trend lower; Pfizer, Dynavax gain 2:34 p.m. Dec. 9, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 4:43 p.m. Nov. 10, 2009 - MarketWatch
Dynavax to buy Symphony Dynamo 7:00 a.m. Nov. 10, 2009 - William L. Watts
Symphony to own 24% of Dynavax 6:49 a.m. Nov. 10, 2009 - Steve Goldstein
Dynavax to issue 13 million shares 6:49 a.m. Nov. 10, 2009 - Steve Goldstein
Dynavax to buy Symphony Dynamo 6:48 a.m. Nov. 10, 2009 - Steve Goldstein
Friday's biggest gaining and declining stocks 5:00 p.m. Sept. 11, 2009 - MarketWatch
Dynavax retrenches; drug stocks mixed 1:18 p.m. Sept. 11, 2009 - Val Brickates Kennedy
Thursday's biggest gaining and declining stocks 4:17 p.m. Sept. 10, 2009 - MarketWatch
Dynavax, Generex rocket as drug stocks gain 1:23 p.m. Sept. 10, 2009 - Val Brickates Kennedy


Dynavax Submits Response to EMA - Analyst Blog 12:10 p.m. Dec. 24, 2013 - Zacks.com
Make Or Break Catalysts Approaching For Dynavax 8:28 a.m. Dec. 24, 2013 - Seeking Alpha
Dynavax: Embarking On A Run Propelled By 2 Potential Approvals 3:33 a.m. Dec. 19, 2013 - Seeking Alpha
Dynavax Technologies (DVAX) Catches Eye: Stock Rises 5.2% - Tale of the Tape 9:18 a.m. Nov. 25, 2013 - Zacks.com
Dynavax Technologies (DVAX) in Focus: Stock Moves 5.8% Higher - Tale of the Tape 9:18 a.m. Nov. 20, 2013 - Zacks.com
Getting Ultra-Bullish On Dynavax 6:56 a.m. Nov. 18, 2013 - Seeking Alpha
Dynavax Technologies: 6 Reasons To Buy 11:24 a.m. Nov. 17, 2013 - Seeking Alpha
Insiders Are Buying These Speculative Biotech Stocks 10:05 a.m. Nov. 11, 2013 - Seeking Alpha
Dynavax Reports In-Line Loss, Beats Rev - Analyst Blog 12:00 p.m. Nov. 8, 2013 - Zacks.com
Jefferies Reiterates on Dynavax Technologies Awaiting Initiation of HBV-23 Safety Trial 7:44 a.m. Nov. 8, 2013 - benzinga.com
Top Three Largest Insider Buys of the Past Week 4:41 p.m. Nov. 5, 2013 - GuruFocus.com
AGCO Corporation Director Buys 343K Shares and 4 Insider Buys to Note 8:10 a.m. Nov. 1, 2013 - Wall St. Cheat Sheet
Insiders Are Buying Dynavax 3:11 p.m. Oct. 31, 2013 - Seeking Alpha
Dynavax: New Phase 3 Clinical Study Finalized For HEPLISAV 4:00 a.m. Oct. 17, 2013 - Seeking Alpha
Dynavax Issues Update on HEPLISAV's Regulatory Path, Will Host Call Tomorrow 3:11 p.m. Oct. 16, 2013 - benzinga.com
Pipeline Progress at Dynavax - Analyst Blog 11:10 a.m. Oct. 15, 2013 - Zacks.com
Dynavax Initiates Phase I Trial In Its Asthma Program 8:19 a.m. Oct. 10, 2013 - Seeking Alpha
Some Speculative Biotechs Making Major Moves 12:36 p.m. Sept. 25, 2013 - Seeking Alpha
Data on Dynavax' Heplisav - Analyst Blog 11:00 a.m. Sept. 25, 2013 - Zacks.com
Dynavax Says Phase 3 Data on HEPLISAV for Adults Age 40-70 Published in VACCINE 2:01 p.m. Sept. 24, 2013 - benzinga.com


Board Appointments, Ratings Upgrade, Successful Deployments, Submissions, and Conferences - Research Report on Health Care REIT, Ventas, Masimo, Dynavax, and Magellan 8:00 a.m. Dec. 24, 2013 - PR Newswire
Dynavax Announces Submission of Responses to EMA Day 120 List of Questions for HEPLISAV(TM) MAA 9:01 a.m. Dec. 19, 2013 - Marketwire
Stock Market Dailies: Teva Pharma Industries, Dynavax Technologies, Covidien, and Valeant Pharma Intl. 10:22 a.m. Dec. 11, 2013 - PR Newswire
Marketing Approval, Presentation Schedules, Supplier Agreement, and Management Changes - Research Report on ImmunoGen, Endologix, Unilife, Sangamo, and Dynavax 8:00 a.m. Dec. 5, 2013 - PR Newswire
Dynavax Announces Resignation of J. Tyler Martin From Board of Directors 4:46 p.m. Nov. 27, 2013 - Marketwire
ARIA, SIRI, DVAX and UNXL added to NASDAQ Active Stock Watch List at GSR 10:11 a.m. Nov. 25, 2013 - ACCESSWIRE
Technical Study: Teva Pharma Industries Ltd, Covidien PLC, Dynavax Technologies Corp., and Valeant Pharma Intl. Inc. 8:00 a.m. Nov. 15, 2013 - PR Newswire
Dynavax Reports Third Quarter 2013 Financial Results 5:10 p.m. Nov. 7, 2013 - Marketwire
Market Briefing: Emerging Growth NASDAQ Stocks in the News 2:22 p.m. Oct. 25, 2013 - PR Newswire
Dynavax Prices Public Offerings of Common Stock and Series B Convertible Preferred Stock 7:30 a.m. Oct. 25, 2013 - Marketwire
Dynavax Announces Proposed Public Offerings of Common Stock and Series B Convertible Preferred Stock 3:01 p.m. Oct. 24, 2013 - Marketwire
Pre-Market Review: Teva Pharma Industries Ltd, Dynavax Technologies Corp., Covidien PLC, and Valeant Pharma Intl. Inc. 8:39 a.m. Oct. 24, 2013 - PR Newswire
Dynavax Reports on HEPLISAV(TM) Regulatory Path 4:09 p.m. Oct. 16, 2013 - Marketwire
Dynavax Initiates First Human Trial in Asthma Program 4:46 p.m. Oct. 9, 2013 - Marketwire
Today's Technical View: Avanir Pharmaceuticals Inc., Warner Chilcott PLC, Actavis Inc., and Dynavax Technologies Corp. 10:48 a.m. Oct. 1, 2013 - PR Newswire
Phase 3 Data on HEPLISAV(TM) in Adults Aged 40-70 and Patients With Chronic Kidney Disease Published in VACCINE 3:00 p.m. Sept. 24, 2013 - Marketwire
Today's Research: Avanir Pharmaceuticals Inc., Warner Chilcott plc, Actavis Inc., and Dynavax Technologies Corp. 7:00 a.m. Aug. 28, 2013 - PR Newswire
Zeldes Haeggquist & Eck, LLP Announces Investigation of Dynavax Technologies Corporation 8:01 a.m. Aug. 16, 2013 - BusinessWire
Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Dynavax Technologies Corporation 9:54 p.m. Aug. 13, 2013 - BusinessWire
UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Dynavax Technologies Corporation of Class Action Lawsuit and Deadline of August 19, 2013 to Seek Lead Plaintiff Position 3:37 p.m. Aug. 12, 2013 - GlobeNewswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 342

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 178

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 44

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 13

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 292

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 34

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 64

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 175

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading

Top 5 Most Recently Viewed Articles

Orion Corporation's Manager Transactions Highlight Executive Moves

Updated Category News Views 133

Understanding Orion Corporation's Executive Transactions Orion Corporation, a prominent player in the global pharmaceutical industry, has recently disclosed significant transactions involving its management, shedding light on financial movements that reflect company growth and strategy. Key Details on Managerial Transactions Recently, Orion Corporation reported under the...

Continue Reading
Congressman Questions SEC's 'Digital Asset Security' Definition

Updated Category News Views 150

Congressman Ritchie Torres Questions SEC's Use of Terminology Representative Ritchie Torres, a Democratic representative from New York, has recently shared his concerns about the phrase "digital asset security" as used by the U.S. Securities and Exchange Commission (SEC). He’s particularly interested in the legal basis and origins of this term. Congressional Dialogue...

Continue Reading
Investigating Claims for StubHub Investors: Your Options

Updated Category News Views 173

Investigation of Claims on Behalf of StubHub Investors Faruqi & Faruqi, LLP, a prominent name in national securities law, is currently looking into potential claims related to StubHub Holdings, Inc. (NYSE: STUB). This initiative aims to assist investors who might have faced losses due to the misleading statements made about the company's financial performance during its...

Continue Reading
Sarepta Therapeutics Faces Class Action Amid Safety Concerns

Updated Category News Views 256

Introduction to Sarepta Therapeutics Sarepta Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative therapies for rare diseases, particularly those associated with genetic factors. The company is well-known for its gene therapy treatments and aims to revolutionize treatment options for patients with Duchenne muscular dystrophy and similar...

Continue Reading